Christopher Pittenger, MD, PhD
- 6Articles
- 32KReads1
- 2005–2017Active
- 20Collaborators
- 237Citations2
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
Christopher Pittenger, MD, PhD, has published extensively on obsessive-compulsive and related disorders, focusing on treatment-resistant cases and pharmacological augmentation strategies. His work includes clinical trials investigating agents such as N-acetylcysteine and riluzole, as well as meta-analyses of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. Pittenger has also contributed to research on delirium, gabapentin abuse, and neuropsychiatric symptoms associated with borderline personality disorder. His publications span from 2005 to 2017 in peer-reviewed psychiatric and neurological journals.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
